Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer

BACKGROUND: Neoadjuvant stereotactic body radiotherapy (SBRT) has potential applicability in the management of borderline resectable and locally-advanced pancreatic adenocarcinoma. In this series, we report the pathologic outcomes in the subset of patients who underwent surgery after neoadjuvant SBR...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajagopalan, Malolan S, Heron, Dwight E, Wegner, Rodney E, Zeh, Herbert J, Bahary, Nathan, Krasinskas, Alyssa M, Lembersky, Barry, Brand, Randall, Moser, A James, Quinn, Annette E, Burton, Steven A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228466/
https://www.ncbi.nlm.nih.gov/pubmed/24175982
http://dx.doi.org/10.1186/1748-717X-8-254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228466/
https://www.ncbi.nlm.nih.gov/pubmed/24175982
http://dx.doi.org/10.1186/1748-717X-8-254

Ejemplares similares